<DOC>
	<DOCNO>NCT01999556</DOCNO>
	<brief_summary>The purpose study obtain high quality specimen molecular study identification characterization genetic mutation involve pathogenesis familial myeloid malignancy . Specimens obtain de-identified , link basic clinical data , send Washington University ( Division Oncology , St. Louis , MO ) molecular analysis . Some specimen send Washington University may also use quality control analyse .</brief_summary>
	<brief_title>LCI-HEM-SPEC-001 : Tissue Collection Genetic Analysis Acute Myelogenous Leukemia</brief_title>
	<detailed_description>This specimen collection study patient receive standard care treatment AML . Specimens collect 1 ) bone marrow biopsy aspiration , 2 ) peripheral blood , 3 ) skin punch biopsy , 4 ) oral rinse . Collection specimens timepoints determine patient 's standard care physician Investigator .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>Inclusion Criteria Patients must diagnosis acute myelogenous leukemia . Family member patient acute myelogenous leukemia may enrol . Informed consent must provide patient his/her legal guardian accord practice Levine Cancer Institute Carolinas Healthcare System . Exclusion Criteria Known infection Hepatitis B C , HTLV , HIV .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>